{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T02:48:56Z","timestamp":1791946136842,"version":"4.3.4"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,12,13]],"date-time":"2016-12-13T00:00:00Z","timestamp":1481587200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2016,12,13]],"date-time":"2016-12-13T00:00:00Z","timestamp":1481587200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    The mechanisms underlying increased thrombotic risk in chronic myeloproliferative neoplasms (MPN) are incompletely understood. We assessed whether neutrophil extracellular traps (NETs), which promote thrombosis, contribute to the procoagulant state in essential thrombocythemia, polycythemia vera and myelofibrosis (MF) patients. Although MPN neutrophils showed increased basal reactive oxygen species (ROS), enhanced NETosis by unstimulated neutrophils was an infrequent finding, whereas PMA-triggered NETosis was impaired, particularly in MF, due to decreased PMA-triggered ROS production. Elevated circulating nucleosomes were a prominent finding and were higher in patients with advanced disease, which may have potential prognostic implication. Histone-MPO complexes, proposed as specific NET biomarker, were seldomly detected, suggesting NETs may not be the main source of nucleosomes in most patients, whereas their correlation with high LDH points to increased cell turn-over as a plausible origin. Lack of association of nucleosomes or NETs with thrombosis or activation markers does not support their use as predictors of thrombosis although prospective studies in a larger cohort may help define their potential contribution to MPN thrombosis. These results do not provide evidence for relevant\n                    <jats:italic>in vivo<\/jats:italic>\n                    NETosis in MPN patients under steady state conditions, although availability of standardized NET biomarkers may contribute to further research in this field.\n                  <\/jats:p>","DOI":"10.1038\/srep38738","type":"journal-article","created":{"date-parts":[[2016,12,13]],"date-time":"2016-12-13T06:02:40Z","timestamp":1481608960000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":79,"title":["Neutrophil extracellular trap formation and circulating nucleosomes in patients with chronic myeloproliferative neoplasms"],"prefix":"10.1038","volume":"6","author":[{"given":"Cecilia P.","family":"Marin Oyarz\u00fan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agostina","family":"Carestia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola R.","family":"Lev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana C.","family":"Glembotsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel A.","family":"Castro R\u00edos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"Moiraghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felisa C.","family":"Molinas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosana F.","family":"Marta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirta","family":"Schattner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula G.","family":"Heller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,12,13]]},"reference":[{"key":"BFsrep38738_CR1","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1001\/jamaoncol.2015.89","volume":"1","author":"A Tefferi","year":"2015","unstructured":"Tefferi, A. & Pardanani, A. Myeloproliferative neoplasms: a contemporary review. JAMA Oncol. 1, 97\u2013105 (2015).","journal-title":"JAMA Oncol."},{"key":"BFsrep38738_CR2","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1182\/blood-2013-03-460154","volume":"122","author":"T Barbui","year":"2013","unstructured":"Barbui, T., Finazzi, G. & Falanga, A. Myeloproliferative neoplasms and thrombosis. Blood 122, 2176\u20132184 (2013).","journal-title":"Blood"},{"key":"BFsrep38738_CR3","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1182\/blood-2012-01-407981","volume":"120","author":"T Barbui","year":"2012","unstructured":"Barbui, T. et al. Disease characteristics and clinical outcome in young adults with essential hrombocythemia versus early\/prefibrotic primary myelofibrosis. Blood 120, 569\u2013571 (2012).","journal-title":"Blood"},{"key":"BFsrep38738_CR4","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1182\/blood-2006-09-046342","volume":"109","author":"A Carobbio","year":"2007","unstructured":"Carobbio, A. et al. Leukocytosis is a risk factor for thrombosis in essential thrombocythemia: interaction with treatment, standard risk factors, and Jak2 mutation status. Blood 109, 2310\u20132313 (2007).","journal-title":"Blood"},{"key":"BFsrep38738_CR5","doi-asserted-by":"crossref","first-page":"4261","DOI":"10.1182\/blood.V96.13.4261","volume":"96","author":"A Falanga","year":"2000","unstructured":"Falanga, A. et al. Polymorphonuclear leukocyte activation and hemostasis in patients with essential thrombocythemia and polycythemia vera. Blood 96, 4261\u20134266 (2000).","journal-title":"Blood"},{"key":"BFsrep38738_CR6","first-page":"169","volume":"91","author":"E Arellano-Rodrigo","year":"2006","unstructured":"Arellano-Rodrigo, E. et al. Increased platelet and leukocyte activation as contributing mechanisms for thrombosis in essential thrombocythemia and correlation with the JAK2 mutational status. Haematologica 91, 169\u2013175 (2006).","journal-title":"Haematologica"},{"key":"BFsrep38738_CR7","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.cyto.2010.04.011","volume":"51","author":"NP Goette","year":"2010","unstructured":"Goette, N. P. et al. Monocyte IL-2Ralpha expression is associated with thrombosis and the JAK2V617F mutation in myeloproliferative neoplasms. Cytokine 51, 67\u201372 (2010).","journal-title":"Cytokine"},{"key":"BFsrep38738_CR8","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1200\/JCO.2010.32.9490","volume":"29","author":"A Tefferi","year":"2011","unstructured":"Tefferi, A. et al. Circulating interleukin (IL)-8, IL-2R, IL-12, and IL-15 levels are independently prognostic in primary myelofibrosis: a comprehensive cytokine profiling study. J Clin Oncol 29, 1356\u20131363 (2011).","journal-title":"J Clin Oncol"},{"key":"BFsrep38738_CR9","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1182\/asheducation.V2012.1.571.3798557","volume":"2012","author":"A Falanga","year":"2012","unstructured":"Falanga, A. & Marchetti, M. Thrombotic disease in the myeloproliferative neoplasms. Hematology Am Soc Hematol Educ Program 2012, 571\u2013581 (2012).","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"BFsrep38738_CR10","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1126\/science.1092385","volume":"303","author":"V Brinkmann","year":"2004","unstructured":"Brinkmann, V. et al. Neutrophil extracellular traps kill bacteria. Science 303, 1532\u20131535 (2004).","journal-title":"Science"},{"key":"BFsrep38738_CR11","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1083\/jcb.200606027","volume":"176","author":"TA Fuchs","year":"2007","unstructured":"Fuchs, T. A. et al. Novel cell death program leads to neutrophil extracellular traps. J Cell Biol 176, 231\u2013241 (2007).","journal-title":"J Cell Biol"},{"key":"BFsrep38738_CR12","doi-asserted-by":"crossref","first-page":"e48111","DOI":"10.1371\/journal.pone.0048111","volume":"7","author":"RS Keshari","year":"2012","unstructured":"Keshari, R. S. et al. Cytokines induced neutrophil extracellular traps formation: implication for the inflammatory disease condition. PLoS One 7, e48111 (2012).","journal-title":"PLoS One"},{"key":"BFsrep38738_CR13","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.1172\/JCI61303","volume":"122","author":"A Caudrillier","year":"2012","unstructured":"Caudrillier, A. et al. Platelets induce neutrophil extracellular traps in transfusion-related acute lung injury. J Clin Invest 122, 2661\u20132671 (2012).","journal-title":"J Clin Invest"},{"key":"BFsrep38738_CR14","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1189\/jlb.3A0415-161R","volume":"99","author":"A Carestia","year":"2016","unstructured":"Carestia, A. et al. Mediators and molecular pathways involved in the regulation of neutrophil extracellular trap formation mediated by activated platelets. J Leukoc Biol 99, 153\u2013162 (2016).","journal-title":"J Leukoc Biol"},{"key":"BFsrep38738_CR15","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/nm.1959","volume":"15","author":"K Kessenbrock","year":"2009","unstructured":"Kessenbrock, K. et al. Netting neutrophils in autoimmune small-vessel vasculitis. Nat Med; 15, 623\u2013625 (2009).","journal-title":"Nat Med"},{"key":"BFsrep38738_CR16","doi-asserted-by":"crossref","first-page":"15880","DOI":"10.1073\/pnas.1005743107","volume":"107","author":"TA Fuchs","year":"2010","unstructured":"Fuchs, T. A. et al. Extracellular DNA traps promote thrombosis. Proc Natl Acad Sci USA 107, 15880\u201315885 (2010).","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFsrep38738_CR17","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1182\/blood-2013-10-463646","volume":"123","author":"K Martinod","year":"2014","unstructured":"Martinod, K. & Wagner, D. D. Thrombosis: tangled up in NETs. Blood 123, 2768\u20132776 (2014).","journal-title":"Blood"},{"key":"BFsrep38738_CR18","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/nri3345","volume":"13","author":"B Engelmann","year":"2013","unstructured":"Engelmann, B. & Massberg, S. Thrombosis as an intravascular effector of innate immunity. Nat Rev Immunol 13, 34\u201345 (2013).","journal-title":"Nat Rev Immunol"},{"key":"BFsrep38738_CR19","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/j.1538-7836.2011.04544.x","volume":"10","author":"A Brill","year":"2012","unstructured":"Brill, A. et al. Neutrophil extracellular traps promote deep vein thrombosis in mice. J Thromb Haemost 10, 136\u2013144 (2012).","journal-title":"J Thromb Haemost"},{"key":"BFsrep38738_CR20","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1182\/blood-2013-07-514992","volume":"123","author":"AS Savchenko","year":"2014","unstructured":"Savchenko, A. S. et al. VWF-mediated leukocyte recruitment with chromatin decondensation by PAD4 increases myocardial ischemia\/reperfusion injury in mice. Blood 123, 141\u2013148 (2014).","journal-title":"Blood"},{"key":"BFsrep38738_CR21","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1111\/jth.12571","volume":"12","author":"AS Savchenko","year":"2014","unstructured":"Savchenko, A. S. et al. Neutrophil extracellular traps form predominantly during the organizing stage of human venous thromboembolism development. J Thromb Haemost 12, 860\u2013870 (2014).","journal-title":"J Thromb Haemost"},{"key":"BFsrep38738_CR22","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1160\/TH12-06-0425","volume":"109","author":"OJ de Boer","year":"2013","unstructured":"de Boer, O. J. et al. Neutrophils, neutrophil extracellular traps and interleukin-17 associate with the organisation of thrombi in acute myocardial infarction. Thromb Haemost 109, 290\u2013297 (2013).","journal-title":"Thromb Haemost"},{"key":"BFsrep38738_CR23","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1161\/ATVBAHA.112.300498","volume":"33","author":"ML van Montfoort","year":"2013","unstructured":"van Montfoort, M. L. et al. Circulating nucleosomes and neutrophil activation as risk factors for deep vein thrombosis. Arterioscler Thromb Vasc Biol 33, 147\u2013151 (2013).","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"BFsrep38738_CR24","doi-asserted-by":"crossref","first-page":"e111755","DOI":"10.1371\/journal.pone.0111755","volume":"9","author":"T Hirose","year":"2014","unstructured":"Hirose, T. et al. Presence of neutrophil extracellular traps and citrullinated histone H3 in the bloodstream of critically ill patients. PLoS One 9, e111755 (2014).","journal-title":"PLoS One"},{"key":"BFsrep38738_CR25","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1038\/nm.3887","volume":"21","author":"SL Wong","year":"2015","unstructured":"Wong, S. L. et al. Diabetes primes neutrophils to undergo NETosis, which impairs wound healing. Nat Med 21, 815\u2013819 (2015).","journal-title":"Nat Med"},{"key":"BFsrep38738_CR26","doi-asserted-by":"crossref","first-page":"13076","DOI":"10.1073\/pnas.1200419109","volume":"109","author":"M Demers","year":"2012","unstructured":"Demers, M. et al. Cancers predispose neutrophils to release extracellular DNA traps that contribute to cancer-associated thrombosis. Proc Natl Acad Sci USA 109, 13076\u201313081 (2012).","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFsrep38738_CR27","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1111\/j.1538-7836.2006.02194.x","volume":"4","author":"N Maugeri","year":"2006","unstructured":"Maugeri, N. et al. Inhibition of tissue factor expression by hydroxyurea in polymorphonuclear leukocytes from patients with myeloproliferative disorders: a new effect for an old drug? J Thromb Haemost 4, 2593\u20132598 (2006).","journal-title":"J Thromb Haemost"},{"key":"BFsrep38738_CR28","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1124\/jpet.112.202879","volume":"345","author":"MJ Lapponi","year":"2013","unstructured":"Lapponi, M. J. et al. Regulation of neutrophil extracellular trap formation by anti-inflammatory drugs. J Pharmacol Exp Ther 345, 430\u2013437 (2013).","journal-title":"J Pharmacol Exp Ther"},{"key":"BFsrep38738_CR29","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.3324\/haematol.2012.082560","volume":"98","author":"M Hurtado-Nedelec","year":"2013","unstructured":"Hurtado-Nedelec, M. et al. Increased reactive oxygen species production and p47phox phosphorylation in neutrophils from myeloproliferative disorders patients with JAK2 (V617F) mutation. Haematologica 98, 1517\u20131524 (2013).","journal-title":"Haematologica"},{"key":"BFsrep38738_CR30","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1002\/ajh.23295","volume":"87","author":"R Vaidya","year":"2012","unstructured":"Vaidya, R. et al. Plasma cytokines in polycythemia vera: phenotypic correlates, prognostic relevance, and comparison with myelofibrosis. Am J Hematol 87, 1003\u20131005 (2012).","journal-title":"Am J Hematol"},{"key":"BFsrep38738_CR31","doi-asserted-by":"crossref","first-page":"R122","DOI":"10.1186\/ar4579","volume":"16","author":"C Sur Chowdhury","year":"2014","unstructured":"Sur Chowdhury, C. et al. Enhanced neutrophil extracellular trap generation in rheumatoid arthritis: analysis of underlying signal transduction pathways and potential diagnostic utility. Arthritis Res Ther. 16, R122 (2014).","journal-title":"Arthritis Res Ther."},{"key":"BFsrep38738_CR32","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.jss.2014.09.033","volume":"194","author":"M Hashiba","year":"2015","unstructured":"Hashiba, M. et al. Neutrophil extracellular traps in patients with sepsis. J Surg Res 194, 248\u2013254 (2015).","journal-title":"J Surg Res"},{"key":"BFsrep38738_CR33","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1182\/blood-2015-01-624023","volume":"126","author":"J Etulain","year":"2015","unstructured":"Etulain, J. et al. P-selectin promotes neutrophil extracellular trap formation in mice. Blood 126, 242\u2013246 (2015).","journal-title":"Blood"},{"key":"BFsrep38738_CR34","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/nchembio.496","volume":"7","author":"A Hakkim","year":"2011","unstructured":"Hakkim, A. et al. Activation of the Raf-MEK-ERK pathway is required for neutrophil extracellular trap formation. Nat Chem Biol 7, 75\u201377 (2011).","journal-title":"Nat Chem Biol"},{"key":"BFsrep38738_CR35","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1200\/JCO.2010.32.2446","volume":"29","author":"N Gangat","year":"2011","unstructured":"Gangat, N. et al. DIPSS plus: a refined Dynamic International Prognostic Scoring System for primary myelofibrosis that incorporates prognostic information from karyotype, platelet count, and transfusion status. J Clin Oncol 29, 392\u2013397 (2011).","journal-title":"J Clin Oncol"},{"key":"BFsrep38738_CR36","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1161\/ATVBAHA.113.301627","volume":"33","author":"JI Borissoff","year":"2013","unstructured":"Borissoff, J. I. et al. Elevated levels of circulating DNA and chromatin are independently associated with severe coronary atherosclerosis and a prothrombotic state. Arterioscler Thromb Vasc Biol 33, 2032\u20132040 (2013).","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"BFsrep38738_CR37","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1038\/leu.2013.102","volume":"27","author":"C Marty","year":"2013","unstructured":"Marty, C. et al. A role for reactive oxygen species in JAK2V617F myeloproliferative neoplasm progression. Leukemia 27, 2187\u20132195 (2013).","journal-title":"Leukemia"},{"key":"BFsrep38738_CR38","doi-asserted-by":"crossref","first-page":"2996","DOI":"10.1182\/blood-2014-04-570572","volume":"124","author":"Y Kagoya","year":"2014","unstructured":"Kagoya, Y. et al. JAK2V617F+ myeloproliferative neoplasm clones evoke paracrine DNA damage to adjacent normal cells through secretion of lipocalin-2. Blood 124, 2996\u20133006 (2014).","journal-title":"Blood"},{"key":"BFsrep38738_CR39","doi-asserted-by":"crossref","first-page":"e123","DOI":"10.1182\/blood-2014-02-554634","volume":"123","author":"R Rampal","year":"2014","unstructured":"Rampal, R. et al. Integrated genomic analysis illustrates the central role of JAK-STAT pathway activation in myeloproliferative neoplasm pathogenesis. Blood 123, e123\u2013133 (2014).","journal-title":"Blood"},{"key":"BFsrep38738_CR40","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/cr.2010.150","volume":"21","author":"Q Remijsen","year":"2011","unstructured":"Remijsen, Q. et al. Neutrophil extracellular trap cell death requires both autophagy and superoxide generation. Cell Res 21, 290\u2013304 (2011).","journal-title":"Cell Res"},{"key":"BFsrep38738_CR41","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1006\/bcmd.1998.0218","volume":"24","author":"B Wolach","year":"1998","unstructured":"Wolach, B., Gavrieli, R., Manor, Y. & Lishner, M. Leukocyte function in chronic myeloproliferative disorders. Blood Cells Mol Dis 24, 544\u2013551 (1998).","journal-title":"Blood Cells Mol Dis"},{"key":"BFsrep38738_CR42","doi-asserted-by":"crossref","first-page":"e1370","DOI":"10.1038\/cddis.2014.337","volume":"5","author":"R Chen","year":"2014","unstructured":"Chen, R., Kang, R., Fan, X. G. & Tang, D. Release and activity of histone in diseases. Cell Death Dis 5, e1370 (2014).","journal-title":"Cell Death Dis"},{"key":"BFsrep38738_CR43","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/1097-0215(20010320)95:2<114::AID-IJC1020>3.0.CO;2-Q","volume":"95","author":"S Holdenrieder","year":"2001","unstructured":"Holdenrieder, S. et al. Nucleosomes in serum of patients with benign and malignant diseases. Int J Cancer 95, 114\u2013120 (2001).","journal-title":"Int J Cancer"},{"key":"BFsrep38738_CR44","doi-asserted-by":"crossref","first-page":"S82","DOI":"10.1111\/jth.12977","volume":"13","author":"TJ Gould","year":"2015","unstructured":"Gould, T. J., Lysov, Z. & Liaw, P. C. Extracellular DNA and histones: double-edged swords in immunothrombosis. J Thromb Haemost 13, Suppl 1 S82\u201391 (2015).","journal-title":"J Thromb Haemost"},{"key":"BFsrep38738_CR45","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1111\/bjh.14077","volume":"173","author":"Y Alhamdi","year":"2016","unstructured":"Alhamdi, Y. & Toh, C. H. The role of extracellular histones in haematological disorders. Br J Haematol 173, 805\u2013811 (2016).","journal-title":"Br J Haematol"},{"key":"BFsrep38738_CR46","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1681\/ASN.2011111077","volume":"23","author":"R Allam","year":"2012","unstructured":"Allam, R. et al. Histones from dying renal cells aggravate kidney injury via TLR2 and TLR4. J Am Soc Nephrol 23, 1375\u20131388 (2012).","journal-title":"J Am Soc Nephrol"},{"key":"BFsrep38738_CR47","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1056\/NEJMoa1002028","volume":"363","author":"S Verstovsek","year":"2010","unstructured":"Verstovsek, S. et al. Safety and efficacy of INCB018424, a JAK1 and JAK2 inhibitor, in myelofibrosis. N Engl J Med 363, 1117\u20131127 (2010).","journal-title":"N Engl J Med"},{"key":"BFsrep38738_CR48","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1182\/blood-2009-03-209262","volume":"114","author":"JW Vardiman","year":"2009","unstructured":"Vardiman, J. W. et al. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood 114, 937\u2013951 (2009).","journal-title":"Blood"},{"key":"BFsrep38738_CR49","doi-asserted-by":"crossref","first-page":"6335","DOI":"10.1182\/blood-2012-01-405183","volume":"119","author":"GM Thomas","year":"2012","unstructured":"Thomas, G. M. et al. Extracellular DNA traps are associated with the pathogenesis of TRALI in humans and mice. Blood 119, 6335\u20136343 (2012).","journal-title":"Blood"},{"key":"BFsrep38738_CR50","doi-asserted-by":"crossref","first-page":"3210","DOI":"10.1111\/trf.12203","volume":"53","author":"TA Fuchs","year":"2013","unstructured":"Fuchs, T. A. et al. Neutrophils release extracellular DNA traps during storage of red blood cell units. Transfusion 53, 3210\u20133216 (2013).","journal-title":"Transfusion"},{"key":"BFsrep38738_CR51","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1160\/TH11-06-0443","volume":"107","author":"J Etulain","year":"2012","unstructured":"Etulain, J. et al. Acidosis downregulates platelet haemostatic functions and promotes neutrophil proinflammatory responses mediated by platelets. Thromb Haemost 107, 99\u2013110 (2012).","journal-title":"Thromb Haemost"},{"key":"BFsrep38738_CR52","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1600-0609.2006.00688.x","volume":"77","author":"PG Heller","year":"2006","unstructured":"Heller, P. G. et al. JAK2V617F mutation in platelets from essential thrombocythemia patients: correlation with clinical features and analysis of STAT5 phosphorylation status. Eur J Haematol 77, 210\u2013216 (2006).","journal-title":"Eur J Haematol"},{"key":"BFsrep38738_CR53","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1111\/j.1600-0609.2010.01421.x","volume":"84","author":"AC Glembotsky","year":"2010","unstructured":"Glembotsky, A. C. et al. Screening for MPL mutations in essential thrombocythemia and primary myelofibrosis: normal Mpl expression and absence of constitutive STAT3 and STAT5 activation in MPLW515L-positive platelets. Eur J Haematol 84, 398\u2013405 (2010).","journal-title":"Eur J Haematol"},{"key":"BFsrep38738_CR54","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/ejh.12614","volume":"96","author":"MJ Mela Osorio","year":"2016","unstructured":"Mela Osorio, M. J. et al. Long-term follow-up of essential thrombocythemia patients treated with anagrelide: subgroup analysis according to JAK2\/CALR\/MPL mutational status. Eur J Haematol 96, 435\u2013442 (2016).","journal-title":"Eur J Haematol"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep38738.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep38738","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep38738.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T22:30:47Z","timestamp":1672871447000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep38738"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12,13]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,12,23]]}},"alternative-id":["BFsrep38738"],"URL":"https:\/\/doi.org\/10.1038\/srep38738","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.727103324.793540025","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12,13]]},"assertion":[{"value":"28 September 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"38738"}}